The first phase would address the transaction’s effect on the national health insurance market. The second phase would focus on the deal’s effect on local markets, with a decision possibly following the first set of arguments.
The DOJ sued to block Indianapolis-based Anthem’s acquisition of Bloomfield, Conn.-based Cigna July 21 over antitrust concerns. The DOJ jointly sued to block Hartford, Conn.-based Aetna’s $37 billion acquisition of Louisville, Ky.-based Humana.
Anthem lawyer Christopher Curran said he thought splitting the trial into two phases was “better,” according to the report.
“If we’re going to lose and we lose quickly, that’s better for everyone,” Mr. Curran said.
The trial is slated to begin Nov. 21 and reach its conclusion by Dec. 30, Reuters reports.
More articles about payer issues:
State-by-state look at ACA individual marketplaces
Feds drop push to end fixed indemnity health plans
New West Health CEO offers insight into insurer’s closure
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
